Farmonic Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 04-01-2025
- Revenue 88.81%
(FY 2022)
- Profit 6.65%
(FY 2022)
- Ebitda 24.13%
(FY 2022)
- Net Worth 210.80%
(FY 2022)
- Total Assets 15.16%
(FY 2022)
About Farmonic Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 Cr.
Darshil Dapki, Yogeshkumar Patel, Chetan Patel, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24303GJ2018PTC104069
- Company No.
104069
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Anand, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Farmonic Biotech?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Patel  | Director | 12-Sep-2018 | Current |
| Darshil Dapki | Director | 12-Sep-2018 | Current |
| Yogeshkumar Patel | Director | 12-Sep-2018 | Current |
| Nishal Dapki | Director | 18-Sep-2019 | Current |
| Sweta Patel | Director | 13-Feb-2020 | Current |
| Rikin Patel | Director | 13-Feb-2020 | Current |
Financial Performance of Farmonic Biotech.
Farmonic Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 88.81% increase. The company also saw a slight improvement in profitability, with a 6.65% increase in profit. The company's net worth Soared by an impressive increase of 210.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Farmonic Biotech?
Unlock access to Farmonic Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Meridian Packaging And Labelling Private LimitedActive 1 year 1 month
Darshil Dapki is a mutual person
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2022 | Hdfc Bank Limited | ₹1.50 Cr | Open |
How Many Employees Work at Farmonic Biotech?
Farmonic Biotech has a workforce of 62 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Farmonic Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farmonic Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
